Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 123

1.

Changes in the commercial brand of tacrolimus lead to subtherapeutic trough levels and acute rejection in renal transplant recipients.

Arreola-Guerra JM, Alberú J, Chew-Wong A, Macias DM, Hernández-Rosales J, Zuñiga-Macías L, Delgadillo-Castañeda R, Ricalde-Ríos G, Haro-Alcalde F, Villafán-Bernal JR, Ramos-Medellín CL, Reyes-Acevedo R.

Clin Transplant. 2019 Nov 5:e13749. doi: 10.1111/ctr.13749. [Epub ahead of print]

PMID:
31691354
2.

"Expanding the limits". Three-year follow-up of renal transplant recipients from a deceased donor with creatinine greater than 5 mg/dl. Report of three cases.

Aguilar-Frasco JL, Rodríguez-Quintero JH, Pastor-Sifuentes FU, Morales-Maza J, Vilatobá M, Alberú J, Contreras-Saldívar AG.

Cir Cir. 2019;87(S1):68-72. doi: 10.24875/CIRU.19000810.

PMID:
31501627
3.

TREATMENT STRATEGIES AND OUTCOME OF PARVOVIRUS B19 INFECTION IN KIDNEY TRANSPLANT RECIPIENTS: A CASE SERIES AND LITERATURE REVIEW OF 128 PATIENTS.

Rosado-Canto R, Carrillo-Pérez DL, Jiménez JV, Cuellar-Rodríguez J, Parra-Avila I, Alberú J, Morales-Buenrostro LE.

Rev Invest Clin. 2019;71(4):265-274. doi: 10.24875/RIC.19002921.

4.

Tissue talks: immunophenotype of cells infiltrating the graft explains histological findings and the benefits of belatacept at 10 years.

Furuzawa-Carballeda J, Uribe-Uribe NO, Arreola-Guerra JM, Reyes-Acevedo R, Vilatobá M, López-Toledo A, Mondragón-Salgado G, Chávez-Fernández R, López-Verdugo F, Mondragón-Ramírez G, Alberú J.

Clin Exp Immunol. 2019 Aug;197(2):250-261. doi: 10.1111/cei.13296. Epub 2019 Apr 15.

PMID:
30916387
5.

First kidney domino transplant in Mexico.

Martínez Calderón P, Cruz Martínez R, Parmentier de León C, Grimaldo Rico OE, Castelán Carmona N, Madrigal Bustamante JA, Rodríguez Covarrubias F, Gabilondo Pliego B, Morales Buenrostro LE, Alberú J, Contreras AG, Vilatobá M.

Nefrologia. 2019 Jul - Aug;39(4):452-454. doi: 10.1016/j.nefro.2018.10.001. Epub 2018 Dec 9. English, Spanish. No abstract available.

6.

Pretransplant angiotensin II type 1-receptor antibodies point to an increase in renal graft sub-intimal fibrosis in living- donor kidney transplant recipients.

González-Almada A, Arreola-Guerra JM, López-Sánchez JA, Cuevas E, Vilatoba M, Contreras AG, Morales-Buenrostro LE, Alberu J, Uribe-Uribe NO.

Transpl Immunol. 2019 Jun;54:1-8. doi: 10.1016/j.trim.2018.10.003. Epub 2018 Oct 15.

PMID:
30336216
7.

Fosfomycin trometamol in the prophylaxis of post-kidney transplant urinary tract infection: A controlled, randomized clinical trial.

Arreola-Guerra JM, Rosado-Canto R, Alberú J, Maravilla E, Torres-González P, Criollo E, Pérez M, Mancilla E, Arvizu M, Morales-Buenrostro LE, Vilatobá-Chapa M, Sifuentes-Osornio J.

Transpl Infect Dis. 2018 Oct;20(5):e12980. doi: 10.1111/tid.12980. Epub 2018 Sep 10.

PMID:
30133928
8.

Value of C3d assay and IgG subclass in the prediction of the flow cytometry cross-match result for renal transplantation.

Contreras AG, Casillas-Abundis A, Alberú J, Llorente L, Lima G, Arvizu A, de Santiago A, Vilatobá M, Granados J, Morales-Buenrostro LE, Cruz R, Arreola-Guerra JM.

Transpl Immunol. 2018 Oct;50:8-14. doi: 10.1016/j.trim.2018.05.002. Epub 2018 Jun 6.

PMID:
29885443
9.

Intellectual performance of kidney transplant recipients' offspring: a cross-sectional, multicenter study.

Morales-Buenrostro LE, Alberu J, Mancilla-Urrea E, Vélez-García A, Espinoza-Pérez R, Cruz-Santiago J, Parra-Michel R, Parra-Avila I, Flores-Nava G, Caballero-Andrade G, Niebla-Cardenas A, Pérez-Avendaño R, Angulo-Dominguez A, Lascarez S, Sánchez-Román S.

J Matern Fetal Neonatal Med. 2019 Feb;32(4):542-549. doi: 10.1080/14767058.2017.1384805. Epub 2017 Oct 8.

PMID:
28988522
10.

Graft immunologic events in deceased donor kidney transplant recipients with preformed HLA-donor specific antibodies.

Ixtlapale-Carmona X, Arvizu A, De-Santiago A, González-Tableros N, López M, Castelán N, Marino LA, Uribe-Uribe NO, Contreras AG, Vilatobá M, Morales-Buenrostro LE, Alberú J.

Transpl Immunol. 2018 Feb;46:8-13. doi: 10.1016/j.trim.2017.09.006. Epub 2017 Sep 30.

PMID:
28974434
11.

KDIGO Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors.

Lentine KL, Kasiske BL, Levey AS, Adams PL, Alberú J, Bakr MA, Gallon L, Garvey CA, Guleria S, Li PK, Segev DL, Taler SJ, Tanabe K, Wright L, Zeier MG, Cheung M, Garg AX.

Transplantation. 2017 Aug;101(8S Suppl 1):S1-S109. doi: 10.1097/TP.0000000000001769.

12.

Summary of Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors.

Lentine KL, Kasiske BL, Levey AS, Adams PL, Alberú J, Bakr MA, Gallon L, Garvey CA, Guleria S, Li PK, Segev DL, Taler SJ, Tanabe K, Wright L, Zeier MG, Cheung M, Garg AX.

Transplantation. 2017 Aug;101(8):1783-1792. doi: 10.1097/TP.0000000000001770. Review.

13.

Methylation of FOXP3 TSDR Underlies the Impaired Suppressive Function of Tregs from Long-term Belatacept-Treated Kidney Transplant Patients.

Alvarez Salazar EK, Cortés-Hernández A, Alemán-Muench GR, Alberú J, Rodríguez-Aguilera JR, Recillas-Targa F, Chagoya de Sánchez V, Cuevas E, Mancilla-Urrea E, Pérez García M, Mondragón-Ramírez G, Vilatobá M, Bostock I, Hernández-Méndez E, De Rungs D, García-Zepeda EA, Soldevila G.

Front Immunol. 2017 Mar 3;8:219. doi: 10.3389/fimmu.2017.00219. eCollection 2017.

14.

Anti-HLA-DQ antibodies are highly and independently related to the C1q-binding capacity of HLA antibodies.

Arreola-Guerra JM, Morales-Buenrostro LE, Granados J, Castelán N, de Santiago A, Arvizu A, Gonzalez-Tableros N, López M, Vilatobá M, Alberú J.

Transpl Immunol. 2017 Mar;41:10-16. doi: 10.1016/j.trim.2017.02.003. Epub 2017 Mar 8.

PMID:
28284929
15.

Safety and Efficacy Outcomes 3 Years After Switching to Belatacept From a Calcineurin Inhibitor in Kidney Transplant Recipients: Results From a Phase 2 Randomized Trial.

Grinyó JM, Del Carmen Rial M, Alberu J, Steinberg SM, Manfro RC, Nainan G, Vincenti F, Jones-Burton C, Kamar N.

Am J Kidney Dis. 2017 May;69(5):587-594. doi: 10.1053/j.ajkd.2016.09.021. Epub 2016 Nov 23.

16.

C1Q Assay Results in Complement-Dependent Cytotoxicity Crossmatch Negative Renal Transplant Candidates with Donor-Specific Antibodies: High Specificity but Low Sensitivity When Predicting Flow Crossmatch.

Arreola-Guerra JM, Castelán N, de Santiago A, Arvizu A, Gonzalez-Tableros N, López M, Salcedo I, Vilatobá M, Granados J, Morales-Buenrostro LE, Alberú J.

J Transplant. 2016;2016:2106028. doi: 10.1155/2016/2106028. Epub 2016 Sep 4.

17.

Impact of pretransplant exposure to allosensitization factors generating HLA antibodies in the Luminex era.

Guichard-Romero A, Marino-Vazquez LA, Castelán N, López M, González-Tableros N, Arvizu A, De Santiago A, Alberú J, Morales-Buenrostro LE.

Transpl Immunol. 2016 Sep;38:33-9. doi: 10.1016/j.trim.2016.08.003. Epub 2016 Aug 20.

PMID:
27553730
18.

Facing the Metabolic Syndrome Epidemic in Living Kidney Donor Programs.

Mejía-Vilet JM, Córdova-Sánchez BM, Arreola-Guerra JM, Alberú J, Morales-Buenrostro LE.

Ann Transplant. 2016 Jul 22;21:456-62.

19.

Pretransplant angiotensin II type 1-receptor antibodies are a risk factor for earlier detection of de novo HLA donor-specific antibodies.

Cuevas E, Arreola-Guerra JM, Hernández-Méndez EA, Salcedo I, Castelán N, Uribe-Uribe NO, Vilatobá M, Contreras-Saldívar AG, Sánchez-Cedillo AI, Ramírez JB, de Rungs D, Granados J, Morales-Buenrostro LE, Alberú J.

Nephrol Dial Transplant. 2016 Oct;31(10):1738-45. doi: 10.1093/ndt/gfw204. Epub 2016 May 24.

PMID:
27220757
20.

Tacrolimus Trough Levels as a Risk Factor for Acute Rejection in Renal Transplant Patients.

Arreola-Guerra JM, Serrano M, Morales-Buenrostro LE, Vilatobá M, Alberú J.

Ann Transplant. 2016 Feb 16;21:105-14.

21.
22.

Increased phosphorylation of the renal Na+-Cl- cotransporter in male kidney transplant recipient patients with hypertension: a prospective cohort.

Rojas-Vega L, Jiménez-Vega AR, Bazúa-Valenti S, Arroyo-Garza I, Jiménez JV, Gómez-Ocádiz R, Carrillo-Pérez DL, Moreno E, Morales-Buenrostro LE, Alberú J, Gamba G.

Am J Physiol Renal Physiol. 2015 Nov 15;309(10):F836-42. doi: 10.1152/ajprenal.00326.2015. Epub 2015 Sep 2.

23.

Is Mexico Ready for Face Transplantation?

Iglesias M, Butrón P, Osuna-Leal AI, Abarca-Perez L, Sosa-Ascencio MJ, Moran-Romero MA, Cruz-Reyes AU, Pineda-Gutierrez FJ, Leon-Lopez DA, García-Alvarez MN, Alberu J, Vilatoba M, Leal-Villalpando RP, Zamudio-Bautista J, Acosta-Nava VM, Gonzalez J.

Transplant Proc. 2015 Jul-Aug;47(6):1998-2002. doi: 10.1016/j.transproceed.2015.05.020. Review.

PMID:
26293088
24.

Effect of Ramipril on Urinary Protein Excretion in Maintenance Renal Transplant Patients Converted to Sirolimus.

Mandelbrot DA, Alberú J, Barama A, Marder BA, Silva HT Jr, Flechner SM, Flynn A, Healy C, Li H, Tortorici MA, Schulman SL.

Am J Transplant. 2015 Dec;15(12):3174-84. doi: 10.1111/ajt.13384. Epub 2015 Jul 14.

25.

Changes in frequency of delayed graft function in deceased donor renal transplant recipient in a tertiary care center in Mexico.

Noriega-Salas AL, Alberú J, Sánchez-Cedillo AI, Navarro-Vargas L, Visag V, Vintimilla-Moscoso A, López-Jiménez JL, Madrigal-Bustamante J, Contreras AG, Vilatobá-Chapa M.

Rev Invest Clin. 2015 Mar-Apr;67(2):89-97.

26.

Pre-transplant angiotensin II type 1receptor antibodies: a risk factor for decreased kidney graft function in the early post-transplant period?

Hernández-Méndez EA, Arreola-Guerra JM, Morales-Buenrostro LE, Ramírez JB, Calleja S, Castelán N, Salcedo I, Vilatobá M, Contreras AG, Gabilondo B, Granados J, Alberú J.

Rev Invest Clin. 2014 May-Jun;66(3):218-24.

PMID:
25695237
27.

C1q Assay Results in Complement-Dependent Cytotoxicity Crossmatch Negative Renal Transplant Candidates with Donor-Specific Antibodies: High Specificity But Low Sensitivity When Predicting Flow Crossmatch.

Arreola-Guerra JM, Morales-Buenrostro LE, Castelán N, de Santiago A, Arvizu A, Gonzalez-Tableros N, López M, Vilatobá M, Granados J, Alberú J.

Clin Transpl. 2015;31:285-292.

PMID:
28514590
28.

A Three-Gene Assay for Monitoring Immune Quiescence in Kidney Transplantation.

Roedder S, Li L, Alonso MN, Hsieh SC, Vu MT, Dai H, Sigdel TK, Bostock I, Macedo C, Metes D, Zeevi A, Shapiro R, Salvatierra O, Scandling J, Alberu J, Engleman E, Sarwal MM.

J Am Soc Nephrol. 2015 Aug;26(8):2042-53. doi: 10.1681/ASN.2013111239. Epub 2014 Nov 26.

29.

Renal transplant recipient with advanced HIV infection: graft and peripheral cell population analysis.

Bostock IC, Furuzawa-Carballeda J, Gómez-Martín D, Lima G, Martin-Onraët A, Sierra J, Uribe-Uribe NO, Vilatobá M, Contreras AG, Gabilondo B, Morales-Buenrostro LE, Alberú J.

Clin Case Rep. 2013 Dec;1(2):79-85. doi: 10.1002/ccr3.28. Epub 2013 Nov 18.

30.

A pilot study on dual-energy computed tomography for detection of urate deposits in renal transplant patients with asymptomatic hyperuricemia.

Kimura-Hayama E, Criales-Vera S, Nicolaou S, Betanzos JL, Rivera Y, Alberú J, Rull-Gabayet M, Hernández-Molina G.

J Clin Rheumatol. 2014 Sep;20(6):306-9. doi: 10.1097/RHU.0000000000000140.

PMID:
25160012
31.

Immunophenotyping of peripheral immunoregulatory as well as Th17A and Th22 cell subpopulations in kidney transplant recipients under belatacept or cyclosporine treatment.

Furuzawa-Carballeda J, Bostock IC, Lima G, Mancilla-Urrea E, Mondragón G, Reyes-Acevedo R, Chevaile A, Morales-Buenrostro LE, Llorente L, Alberú J.

Transpl Immunol. 2014 Mar;30(2-3):107-13. doi: 10.1016/j.trim.2014.02.002. Epub 2014 Feb 18.

PMID:
24561014
32.

Fever, haematuria, and acute graft dysfunction in renal transplant recipients secondary to adenovirus infection: two case reports.

Ramírez J, Bostock IC, Martin-Onraët A, Calleja S, Sánchez-Cedillo A, Navarro-Vargas LA, Noriega-Salas AL, Martínez-Mijangos O, Uribe-Uribe NO, Vilatoba M, Gabilondo B, Morales-Buenrostro LE, Alberú J.

Case Rep Nephrol. 2013;2013:195753. doi: 10.1155/2013/195753. Epub 2013 Feb 14.

33.

Minor H antigen matches and mismatches are equally distributed among recipients with or without complications after HLA identical sibling renal transplantation.

Dierselhuis MP, Spierings E, Drabbels J, Hendriks M, Alaez C, Alberú J, Alvarez MB, Burlingham W, Campos E, Christiaans M, Claas F, Fasano ME, Gerbase-Delima M, Gervais T, Gorodezky C, Larriba J, Lardy NM, Latinne D, Morales-Buenrostro LE, Moreno MJ, Oguz F, Opelz G, Sergeant R, Tambutti M, Teper S, Tilanus M, Turkmen A, Warrens AN, Weimar W, Goulmy E.

Tissue Antigens. 2013 Nov;82(5):312-6. doi: 10.1111/tan.12209. Epub 2013 Oct 4.

PMID:
24116658
34.

Seroprevalence of Trypanosoma cruzi in kidney transplant donors and recipients in Mexico City.

Rodríguez-Romo R, Morales-Buenrostro LE, Reyes PA, Gracida C, Medeiros M, Mancilla E, De Leo C, Alberú J.

Transpl Infect Dis. 2013 Dec;15(6):639-44. doi: 10.1111/tid.12122. Epub 2013 Aug 1.

PMID:
23901935
35.

[Risk factors in the development of delayed graft function in deceased donor kidney transplant recipients and their impact on patient and graft survival].

Pérez-Gutiérrez A, Morales-Buenrostro LE, Vilatobá-Chapa M, Mendoza-De-la-garza A, Vega-Vega O, Gabilondo-Pliego B, Alberú J.

Rev Invest Clin. 2013 Mar-Apr;65(2):109-15. Spanish.

PMID:
23844529
36.

Probability of deceased donor kidney transplantation based on % PRA.

Bostock IC, Alberú J, Arvizu A, Hernández-Mendez EA, De-Santiago A, González-Tableros N, López M, Castelán N, Contreras AG, Morales-Buenrostro LE, Gabilondo B, Vilatobá M.

Transpl Immunol. 2013 Jun;28(4):154-8. doi: 10.1016/j.trim.2013.05.002. Epub 2013 May 16.

37.

Mineralocorticoid receptor blockade reduced oxidative stress in renal transplant recipients: a double-blind, randomized pilot study.

Ojeda-Cervantes M, Barrera-Chimal J, Alberú J, Pérez-Villalva R, Morales-Buenrostro LE, Bobadilla NA.

Am J Nephrol. 2013;37(5):481-90. doi: 10.1159/000350539. Epub 2013 Apr 30.

PMID:
23635604
38.

Law on advance directives in Mexico.

Cantú G, Alberú J.

Nefrologia. 2013 Jan 18;33(1):142-3. doi: 10.3265/Nefrologia.pre2012.Jun.11534. English, Spanish. No abstract available.

39.

Pre-nephrectomy angiotensin II type 1 receptor antibodies in living kidney donors: A concern?

Hernández-Méndez EA, Arreola-Guerra JM, Morales-Buenrostro LE, Ramírez JB, Calleja S, Castelán N, Salcedo I, Vilatobá M, Contreras AG, Gabilondo B, Granados J, Alberú J.

Clin Transpl. 2013:351-5.

PMID:
25095528
40.

Pre-transplant angiotensin II type 1 receptor antibodies: A risk factor for decreased kidney graft function in the early post-transplant period?

Hernández-Méndez EA, Arreola-Guerra JM, Morales-Buenrostro LE, Ramírez JB, Calleja S, Castelán N, Salcedo I, Vilatobá M, Contreras AG, Gabilondo B, Granados J, Alberú J.

Clin Transpl. 2013:343-50.

PMID:
25095527
41.

Peripheral regulatory cells immunophenotyping in kidney transplant recipients with different clinical profiles: a cross-sectional study.

Furuzawa-Carballeda J, Lima G, Simancas P, Ramos-Bello D, Simancas M, Bostock IC, Vilatobá M, Gabilondo B, Granados J, Morales-Buenrostro L, Alberú J, Llorente L.

J Transplant. 2012;2012:256960. doi: 10.1155/2012/256960. Epub 2012 Nov 19.

42.

[Intimidation against renal transplantation scientist].

Esquivel A, González R, Alberú J, Gracida C, Medeiros M, Castañeda-Hernández G.

Rev Invest Clin. 2012 May-Jun;64(3):215-9. Spanish. No abstract available.

PMID:
23045942
43.

De Novo Donor-Specific HLA Antibody Development and Peripheral CD4(+)CD25(high) Cells in Kidney Transplant Recipients: A Place for Interaction?

Alberu J, Vargas-Rojas MI, Morales-Buenrostro LE, Crispin JC, Rodríguez-Romo R, Uribe-Uribe NO, Carrasco G, Gómez-Martín D, Alcocer-Varela J.

J Transplant. 2012;2012:302539. doi: 10.1155/2012/302539. Epub 2012 Aug 23.

44.

Improvement in renal function in kidney transplant recipients switched from cyclosporine or tacrolimus to belatacept: 2-year results from the long-term extension of a phase II study.

Grinyo J, Alberu J, Contieri FL, Manfro RC, Mondragon G, Nainan G, Rial Mdel C, Steinberg S, Vincenti F, Dong Y, Thomas D, Kamar N.

Transpl Int. 2012 Oct;25(10):1059-64. doi: 10.1111/j.1432-2277.2012.01535.x. Epub 2012 Jul 21.

45.

CYP3A5 polymorphism in Mexican renal transplant recipients and its association with tacrolimus dosing.

García-Roca P, Medeiros M, Reyes H, Rodríguez-Espino BA, Alberú J, Ortiz L, Vásquez-Perdomo M, Elizondo G, Morales-Buenrostro LE, Mancilla Urrea E, Castañeda-Hernández G.

Arch Med Res. 2012 May;43(4):283-7. doi: 10.1016/j.arcmed.2012.05.005. Epub 2012 Jun 13.

PMID:
22704849
46.

Extended major histocompatibility complex haplotypes, ancestry and acute kidney transplant rejection in Mexicans.

Riquelme-Mc Loughlin MC, Granados J, Acuña-Alonzo V, Telich-Tarriba JE, Mancilla-Urrea E, Villa AR, de-Leo C, Alberú J, Morales-Buenrostro LE, Madero M.

Rev Invest Clin. 2011 Jul-Aug;63(4):370-5.

PMID:
22364036
47.

Infiltrating cellular pattern in kidney graft biopsies translates into forkhead box protein 3 up-regulation and p16INK4α senescence protein down-regulation in patients treated with belatacept compared to cyclosporin A.

Furuzawa-Carballeda J, Lima G, Alberú J, Palafox D, Uribe-Uribe N, Morales-Buenrostro LE, Reyes Acevedo R, Mondragón G, Chevaile A, Llorente L.

Clin Exp Immunol. 2012 Feb;167(2):330-7. doi: 10.1111/j.1365-2249.2011.04504.x.

48.

A comparative study of the traditional method, and a point-score system for allocation of deceased-donor kidneys: a national multicenter study in Mexico.

Cantú-Quintanilla G, Alberú J, Reyes-Acevedo R, Medeiros M, Villa MS, Arreola JM, Gracida C, Reyes-López A.

Transplant Proc. 2011 Nov;43(9):3327-30. doi: 10.1016/j.transproceed.2011.09.091.

PMID:
22099790
49.

Assessment of emotional distress in chronic kidney disease patients and kidney transplant recipients.

González-De-Jesús LN, Sánchez-Román S, Morales-Buenrostro LE, Ostrosky-Solís F, Alberú J, García-Ramos G, Marino-Vázquez LA, McClintock SM.

Rev Invest Clin. 2011 Nov-Dec;63(6):558-63.

PMID:
23650668
50.

Three-year outcomes from BENEFIT, a randomized, active-controlled, parallel-group study in adult kidney transplant recipients.

Vincenti F, Larsen CP, Alberu J, Bresnahan B, Garcia VD, Kothari J, Lang P, Urrea EM, Massari P, Mondragon-Ramirez G, Reyes-Acevedo R, Rice K, Rostaing L, Steinberg S, Xing J, Agarwal M, Harler MB, Charpentier B.

Am J Transplant. 2012 Jan;12(1):210-7. doi: 10.1111/j.1600-6143.2011.03785.x. Epub 2011 Oct 12.

Supplemental Content

Loading ...
Support Center